Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
30.99
+0.35 (1.14%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Edgewise Therapeutics Employees
Edgewise Therapeutics had 146 employees as of December 31, 2025. The number of employees increased by 36 or 32.73% compared to the previous year.
Employees
146
Change (1Y)
36
Growth (1Y)
32.73%
Revenue / Employee
n/a
Profits / Employee
-$1,149,281
Market Cap
3.32B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Denali Therapeutics | 503 |
| Travere Therapeutics | 497 |
| Alumis | 224 |
| Structure Therapeutics | 220 |
| Catalyst Pharmaceuticals | 182 |
| Tango Therapeutics | 137 |
EWTX News
- 27 days ago - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PRNewsWire
- 6 weeks ago - Edgewise Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Edgewise Announces Positive Long-Term Sevasemten Data Demonstrating Sustained Functional Stabilization in Becker Muscular Dystrophy Through 3.5 Years of Follow-Up - PRNewsWire
- 7 weeks ago - Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026 - PRNewsWire
- 2 months ago - Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference - PRNewsWire
- 2 months ago - Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs - PRNewsWire
- 2 months ago - Edgewise Therapeutics Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts
- 2 months ago - Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026 - PRNewsWire